0XF

6-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(5,6-dimethylpyridin-2-yl)amino]pyridazine-3-carboxamide

Created:	2012-08-24
Last modified:	2013-08-14

Find Related PDB Entry
1 entries where 0XF is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	51
Chiral Atom Count	2
Bond Count	53
Aromatic Bond Count	12

2D diagram of 0XF

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	6-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(5,6-dimethylpyridin-2-yl)amino]pyridazine-3-carboxamide
Systematic Name (OpenEye OEToolkits)	6-[[(1R,2S)-2-azanylcyclohexyl]amino]-4-[(5,6-dimethylpyridin-2-yl)amino]pyridazine-3-carboxamide
Formula	C₁₈ H₂₅ N₇ O
Molecular Weight	355.437
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(c2nnc(cc2Nc1nc(c(cc1)C)C)NC3CCCCC3N)N
SMILES	CACTVS	3.370	Cc1ccc(Nc2cc(N[CH]3CCCC[CH]3N)nnc2C(N)=O)nc1C
SMILES	OpenEye OEToolkits	1.7.6	Cc1ccc(nc1C)Nc2cc(nnc2C(=O)N)NC3CCCCC3N
Canonical SMILES	CACTVS	3.370	Cc1ccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)nc1C
Canonical SMILES	OpenEye OEToolkits	1.7.6	Cc1ccc(nc1C)Nc2cc(nnc2C(=O)N)N[C@@H]3CCCC[C@@H]3N
InChI	InChI	1.03	InChI=1S/C18H25N7O/c1-10-7-8-15(21-11(10)2)23-14-9-16(24-25-17(14)18(20)26)22-13-6-4-3-5-12(13)19/h7-9,12-13H,3-6,19H2,1-2H3,(H2,20,26)(H2,21,22,23,24)/t12-,13+/m0/s1
InChIKey	InChI	1.03	XJZVCDVZCRLIKN-QWHCGFSZSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3237561
PubChem	71626896
ChEMBL	CHEMBL3237561

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.